The global assisted reproductive technology market was valued at USD 21.32 billion in 2018 and is expected to reach USD 45.06 billion by 2026, growing at a CAGR of 9.8%. The U.S. is experiencing significant market growth, driven by rising infertility rates, advancements in medical technologies, and increased awareness of reproductive treatments. In 2018, Europe led the global market with a share of 41.18%.

The assisted reproductive technology (ART) market refers to a broad range of medical procedures used to address infertility and support conception. These technologies include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation, and fertility medication, among others. The market is driven by factors such as rising infertility rates, delayed pregnancies, lifestyle changes, and increased awareness of available fertility treatments. Advances in technology, improved success rates, and expanding access to fertility clinics are further contributing to market growth. As social acceptance of ART increases and more individuals and couples seek fertility solutions, the assisted reproductive technology market is expected to grow steadily, offering new opportunities for innovation and improved patient outcomes.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technology-art-market-101811**

Global Assisted Reproductive Technology Market Overview

Market Size & Forecast

• The global assisted reproductive technology market was valued at USD 21.32 billion in 2018.
• It is projected to reach USD 45.06 billion by 2026, reflecting a CAGR of 9.8% from 2019 to 2026.
• Growth is driven by rising infertility rates, delayed family planning, and increasing awareness and acceptance of ART procedures.

Market Share

• Europe led the global assisted reproductive technology market in 2018 with a 18% share, supported by:
  • High infertility prevalence.
  • Strong demand for ART services.
  • A high number of treatment cycles in countries like Spain, Denmark, the U.K., Germany, and France.
• In Vitro Fertilization (IVF) emerged as the leading segment by technique in 2018, driven by:
  • High procedural success rates.
  • Continuous technological innovations such as time-lapse imaging systems for embryo development monitoring.

Key Country Highlights

• Japan:
  • Increasing infertility rates and decreasing stigma around ART are driving adoption.
  • Rise in the number of licensed fertility clinics is supporting market growth.
• United States:
  • Market growth is fueled by high infertility prevalence, advanced technology, and a well-developed ART infrastructure.
  • Over 1 million babies were born through IVF/ART between 1987 and 2015.
• China:
  • Rapid market expansion is driven by government backing, growing public acceptance, and a high infertility burden.
• Europe:
  • Countries like Spain are performing over 140,000 ART cycles annually, aided by robust healthcare infrastructure and high patient access to fertility services.

Assisted Reproductive Technology Market Segmentation: